• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者阻塞性睡眠呼吸暂停:患病率和预测因素。

Obstructive sleep apnea in patients with interstitial lung disease: Prevalence and predictive factors.

机构信息

Division of Pulmonology, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.

Division of Allergy, Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.

出版信息

PLoS One. 2020 Oct 5;15(10):e0239963. doi: 10.1371/journal.pone.0239963. eCollection 2020.

DOI:10.1371/journal.pone.0239963
PMID:33017401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7535061/
Abstract

Interstitial lung diseases (ILDs) are chronic, progressive, parenchymal lung diseases with high morbidity and mortality. In recent studies, the prevalence of obstructive sleep apnea (OSA) in patients with ILD has been reported to be high. However, the prevalence and predictive factors of OSA in Korean ILD patients are not well defined. Therefore, the aim of this study was to evaluate the prevalence and predictive factors of OSA in Korean patients with ILD. Clinical data from 86 patients with ILD enrolled from December 2017 to April 2019 at Haeundae-Paik Hospital, Busan, South Korea, were retrospectively analyzed. OSA was monitored with a level 4 portable device and defined as an apnea-hypopnea index of more than 5 per hour of sleep. The median follow-up period was 7 months. The mean age was 69.8 years, and 64% of participants were men. Among the ILDs, idiopathic pulmonary fibrosis (IPF) was the most common (66.3%), followed by connective tissue disease-associated ILD (16.3%) and cryptogenic organizing pneumonia (5.8%). Forty-six ILD patients (53.5%) were diagnosed with OSA, and IPF patients had OSA more frequently (64.9% vs. 31.0%, p = 0.003) than those with other ILDs. Older age (odds ratio [OR], 1.11, 95% CI 1.04-1.19, p = 0.002), higher body weight (OR 1.05, 95% CI 1.01-1.10, p = 0.012), and diabetes mellitus (OR 4.03, 95% CI 1.26-12.91, p = 0.019) were independent risk factors for OSA in the multivariable logistic regression analysis. In the multivariable Cox analysis, an IPF diagnosis was a significant risk factor for one-year mortality (hazard ratio [HR] 7.92, 95% CI: 1.01-61.83, p = 0.048) in ILD patients; however, OSA was not. In conclusion, half of Korean patients with ILD had OSA. Older age, higher body weight, and diabetes mellitus were risk factors for OSA in patients with ILD.

摘要

间质性肺疾病(ILDs)是一种慢性、进行性的实质肺疾病,发病率和死亡率均较高。最近的研究表明,ILD 患者阻塞性睡眠呼吸暂停(OSA)的患病率较高。然而,韩国 ILD 患者 OSA 的患病率和预测因素尚未得到明确界定。因此,本研究旨在评估韩国 ILD 患者 OSA 的患病率和预测因素。

本研究回顾性分析了 2017 年 12 月至 2019 年 4 月在韩国釜山海云台拜克医院就诊的 86 例 ILD 患者的临床资料。使用 4 级便携式设备监测 OSA,并将睡眠中每小时呼吸暂停低通气指数超过 5 定义为 OSA。中位随访时间为 7 个月。患者平均年龄为 69.8 岁,64%为男性。ILD 中最常见的是特发性肺纤维化(IPF)(66.3%),其次是结缔组织病相关 ILD(16.3%)和隐源性机化性肺炎(5.8%)。46 例(53.5%)ILD 患者诊断为 OSA,IPF 患者 OSA 的患病率高于其他 ILD 患者(64.9%比 31.0%,p=0.003)。多变量逻辑回归分析显示,年龄较大(比值比[OR],1.11;95%置信区间[CI],1.04-1.19;p=0.002)、体重较高(OR,1.05;95%CI,1.01-1.10;p=0.012)和糖尿病(OR,4.03;95%CI,1.26-12.91;p=0.019)是 OSA 的独立危险因素。多变量 Cox 分析显示,IPF 诊断是 ILD 患者一年死亡率的显著危险因素(风险比[HR],7.92;95%CI:1.01-61.83;p=0.048),而 OSA 不是。

总之,一半的韩国 ILD 患者患有 OSA。年龄较大、体重较高和糖尿病是 ILD 患者 OSA 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e364/7535061/da0101b36f61/pone.0239963.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e364/7535061/da0101b36f61/pone.0239963.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e364/7535061/da0101b36f61/pone.0239963.g001.jpg

相似文献

1
Obstructive sleep apnea in patients with interstitial lung disease: Prevalence and predictive factors.特发性肺纤维化患者阻塞性睡眠呼吸暂停:患病率和预测因素。
PLoS One. 2020 Oct 5;15(10):e0239963. doi: 10.1371/journal.pone.0239963. eCollection 2020.
2
Prevalence and clinical impacts of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: A single-center, retrospective study.特发性肺纤维化患者阻塞性睡眠呼吸暂停的患病率及临床影响:一项单中心回顾性研究。
PLoS One. 2023 Sep 26;18(9):e0291195. doi: 10.1371/journal.pone.0291195. eCollection 2023.
3
First Description of the Hyperpnea-Hypopnea Periodic Breathing in Patients with Interstitial Lung Disease-Obstructive Sleep Apnea: Treatment Implications in a Real-Life Setting.特发性肺纤维化-阻塞性睡眠呼吸暂停患者过度通气-低通气周期呼吸的首次描述:真实环境下的治疗意义。
Int J Environ Res Public Health. 2019 Nov 26;16(23):4712. doi: 10.3390/ijerph16234712.
4
The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.白细胞介素-6 作为预测间质性肺疾病急性加重的预后生物标志物的作用。
PLoS One. 2021 Jul 27;16(7):e0255365. doi: 10.1371/journal.pone.0255365. eCollection 2021.
5
Obstructive sleep apnea in pulmonary fibrosis.肺纤维化中的阻塞性睡眠呼吸暂停。
Curr Opin Pulm Med. 2020 Sep;26(5):443-448. doi: 10.1097/MCP.0000000000000697.
6
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.基于聚类的分析评估纤维化间质性肺疾病合并症的影响。
Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7.
7
A study on the prevalence and prognosis of progressive pulmonary fibrosis: A retrospective observational study.一项关于进展性肺纤维化的患病率和预后的研究:回顾性观察研究。
Medicine (Baltimore). 2024 May 17;103(20):e38226. doi: 10.1097/MD.0000000000038226.
8
Obstructive sleep apnea is common in patients with interstitial lung disease.阻塞性睡眠呼吸暂停在间质性肺疾病患者中很常见。
Sleep Breath. 2013 Dec;17(4):1281-8. doi: 10.1007/s11325-013-0834-3. Epub 2013 Apr 8.
9
The prevalence of obstructive sleep apnea in interstitial lung disease: a systematic review and meta-analysis.间质性肺疾病患者阻塞性睡眠呼吸暂停的患病率:系统评价和荟萃分析。
Sleep Breath. 2021 Sep;25(3):1219-1228. doi: 10.1007/s11325-020-02282-z. Epub 2021 Jan 6.
10
Predictors of obstructive sleep apnea in lung transplant recipients.肺移植受者阻塞性睡眠呼吸暂停的预测因素。
Sleep Med. 2016 May;21:121-5. doi: 10.1016/j.sleep.2016.01.005. Epub 2016 Feb 11.

引用本文的文献

1
Factors affecting quality of life in connective tissue disease-related interstitial lung disease.影响结缔组织病相关间质性肺疾病患者生活质量的因素。
PLoS One. 2025 Jul 31;20(7):e0327462. doi: 10.1371/journal.pone.0327462. eCollection 2025.
2
The Link Between Sleep-Related Breathing Disorders and Idiopathic Pulmonary Fibrosis: Pathophysiological Mechanisms and Treatment Options-A Review.睡眠相关呼吸障碍与特发性肺纤维化之间的联系:病理生理机制与治疗选择——综述
J Clin Med. 2025 Mar 24;14(7):2205. doi: 10.3390/jcm14072205.
3
Assessment of Sleep Disorders in Patients with CVID.

本文引用的文献

1
Obstructive Sleep Apnea in Patients With Fibrotic Interstitial Lung Disease and COPD.特发性肺纤维化和 COPD 患者的阻塞性睡眠呼吸暂停。
J Clin Sleep Med. 2019 Dec 15;15(12):1807-1815. doi: 10.5664/jcsm.8090. Epub 2019 Oct 26.
2
Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease.夜间低氧血症与间质性肺疾病的不良结局相关。
Respirology. 2019 Oct;24(10):996-1004. doi: 10.1111/resp.13549. Epub 2019 Apr 1.
3
Predictive factors of obstructive sleep apnoea in patients with fibrotic lung diseases.
评估 CVID 患者的睡眠障碍。
J Clin Immunol. 2024 Apr 27;44(5):109. doi: 10.1007/s10875-024-01711-y.
4
Prevalence and clinical impacts of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: A single-center, retrospective study.特发性肺纤维化患者阻塞性睡眠呼吸暂停的患病率及临床影响:一项单中心回顾性研究。
PLoS One. 2023 Sep 26;18(9):e0291195. doi: 10.1371/journal.pone.0291195. eCollection 2023.
5
Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study.特发性肺纤维化的流行病学和合并症:一项全国性队列研究。
BMC Pulm Med. 2023 Feb 4;23(1):54. doi: 10.1186/s12890-023-02340-8.
6
Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement.严重呼吸系统疾病患者的照护延续链中的舒缓医疗:美国胸科学会/美国临终关怀与姑息医学学会/美国护士麻醉师协会/世界卫生组织姑息治疗联盟政策声明。
Am J Respir Crit Care Med. 2022 Sep 15;206(6):e44-e69. doi: 10.1164/rccm.202207-1262ST.
7
The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.特发性肺纤维化与阻塞性睡眠呼吸暂停之间的关联:一项系统评价与荟萃分析
J Clin Med. 2022 Aug 26;11(17):5008. doi: 10.3390/jcm11175008.
8
The prevalence of obstructive sleep apnea in interstitial lung disease: a systematic review and meta-analysis.间质性肺疾病患者阻塞性睡眠呼吸暂停的患病率:系统评价和荟萃分析。
Sleep Breath. 2021 Sep;25(3):1219-1228. doi: 10.1007/s11325-020-02282-z. Epub 2021 Jan 6.
肺纤维化疾病患者阻塞性睡眠呼吸暂停的预测因素。
Sleep Med. 2019 Apr;56:123-127. doi: 10.1016/j.sleep.2019.01.020. Epub 2019 Jan 26.
4
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化诊断。美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68. doi: 10.1164/rccm.201807-1255ST.
5
Sleep disorders and health-related quality of life in patients with interstitial lung disease.间质性肺疾病患者的睡眠障碍及与健康相关的生活质量。
Sleep Breath. 2018 May;22(2):393-400. doi: 10.1007/s11325-017-1579-1. Epub 2017 Oct 16.
6
Obstructive sleep apnoea and related comorbidities in incident idiopathic pulmonary fibrosis.特发性肺纤维化患者中的阻塞性睡眠呼吸暂停及其相关合并症。
Eur Respir J. 2017 Jun 8;49(6). doi: 10.1183/13993003.01934-2016. Print 2017 Jun.
7
Obstructive Sleep Apnea and Diabetes: A State of the Art Review.阻塞性睡眠呼吸暂停与糖尿病:最新综述
Chest. 2017 Nov;152(5):1070-1086. doi: 10.1016/j.chest.2017.05.009. Epub 2017 May 17.
8
Screening for Obstructive Sleep Apnea in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.成人阻塞性睡眠呼吸暂停筛查:美国预防服务工作组的证据报告和系统评价。
JAMA. 2017 Jan 24;317(4):415-433. doi: 10.1001/jama.2016.19635.
9
Comorbidities in interstitial lung diseases.间质性肺疾病中的合并症。
Eur Respir Rev. 2017 Jan 3;26(143). doi: 10.1183/16000617.0027-2016. Print 2017 Jan.
10
Use of a portable monitoring device (Somnocheck Micro) for the investigation and diagnosis of obstructive sleep apnoea in comparison with polysomnography.与多导睡眠图相比,使用便携式监测设备(Somnocheck Micro)进行阻塞性睡眠呼吸暂停的调查和诊断。
Pak J Med Sci. 2016 Mar-Apr;32(2):471-5. doi: 10.12669/pjms.322.9561.